Skip to content

Oral Paracetamol as Preemptive Analgesia for Labor Pain

Oral Paracetamol as Preemptive Analgesia for Labor Pain

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01817829
Enrollment
100
Registered
2013-03-26
Start date
2011-12-31
Completion date
2012-06-30
Last updated
2013-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain

Brief summary

It is a double blinded randomized control trial assessing the use of Oral paracetamol in managing the intrapartum pain.

Detailed description

It is a double blinded randomized control trial comparing the use of Oral paracetamol to placebo in managing the intrapartum pain.

Interventions

DRUGparacetamol

500 mg oral tablet

DRUGplacebo

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* primigravida * The gestational age between 37- 42 weeks * Not seeking analgesia * Singleton pregnancy * vertex * Spontaneous onset of labour * 1st stage of labour (less than 5 cm)

Exclusion criteria

* Extreme of age (below18-above 40) * Multiparous * Multiple gestation * Malpresentation * Congenital or acquired pelvic abnormalities(eg. Poliomyelitis) * Any medical disorder with pregnancy * Induction of labour * Advanced 1st stage \> 5 cm * Use of any other kind of analgesia before recruitment in the study * Scared uterus * Fetal distress

Design outcomes

Primary

MeasureTime frameDescription
EfficacyintrapartumTo document the efficacy of oral paracetamol, in pregnant women in labor, as demonstrated by the degree of pain relief and need for additional analgesia during the labor process and the early postpartum period.

Secondary

MeasureTime frameDescription
SafetyStart of medication till 24 hours postpartumTo document safety and evaluate adverse events recorded during the study either maternal or fetal.
Duration of laborStart of medication till delivery of fetus.To assess the effect of the duration of labor.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026